Jantovia M XR 50+500mg is a combination antidiabetic tablet designed for managing type 2 diabetes mellitus. It contains sitagliptin (50mg) and metformin (500mg) in an extended-release formulation, allowing for once-daily dosing that enhances patient compliance. Sitagliptin works by inhibiting DPP-4 enzymes to increase incretin levels, while metformin improves insulin sensitivity and reduces hepatic glucose production. This dual-action approach provides comprehensive glycemic control with a favorable safety profile. Suitable for patients inadequately controlled on monotherapy, it helps reduce HbA1c levels effectively while minimizing hypoglycemia risk.

JANTOVIA M XR 50+500MG TAB